TP53 and neoplasm: Gain-of-function TP53 aberrations accompanied by loss of the tumor-suppressive function typically arise from missense mutations or in-frame deletions, disrupting MDM2 mediated ubiquitin degradation of p53, causing it to accumulate in the tumor cells leading to overexpression.